A machine learning-assisted system to predict thyrotoxicosis using patients' heart rate monitoring data: a retrospective cohort study.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
30 Nov 2023
30 Nov 2023
Historique:
received:
25
09
2023
accepted:
23
11
2023
medline:
4
12
2023
pubmed:
1
12
2023
entrez:
30
11
2023
Statut:
epublish
Résumé
Previous studies have shown a correlation between resting heart rate (HR) measured by wearable devices and serum free thyroxine concentration in patients with thyroid dysfunction. We have developed a machine learning (ML)-assisted system that uses HR data collected from wearable devices to predict the occurrence of thyrotoxicosis in patients. HR monitoring data were collected using a wearable device for a period of 4 months in 175 patients with thyroid dysfunction. During this period, 3 or 4 thyroid function tests (TFTs) were performed on each patient at intervals of at least one month. The HR data collected during the 10 days prior to each TFT were paired with the corresponding TFT results, resulting in a total of 662 pairs of data. Our ML-assisted system predicted thyrotoxicosis of a patient at a given time point based on HR data and their HR-TFT data pair at another time point. Our ML-assisted system divided the 662 cases into either thyrotoxicosis and non-thyrotoxicosis and the performance was calculated based on the TFT results. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of our system for predicting thyrotoxicosis were 86.14%, 85.92%, 52.41%, and 97.18%, respectively. When subclinical thyrotoxicosis was excluded from the analysis, the sensitivity, specificity, PPV, and NPV of our system for predicting thyrotoxicosis were 86.14%, 98.28%, 94.57%, and 95.32%, respectively. Our ML-assisted system used the change in mean, relative standard deviation, skewness, and kurtosis of HR while sleeping, and the Jensen-Shannon divergence of sleep HR and TFT distribution as major parameters for predicting thyrotoxicosis. Our ML-assisted system has demonstrated reasonably accurate predictions of thyrotoxicosis in patients with thyroid dysfunction, and the accuracy could be further improved by gathering more data. This predictive system has the potential to monitor the thyroid function status of patients with thyroid dysfunction by collecting heart rate data, and to determine the optimal timing for blood tests and treatment intervention.
Identifiants
pubmed: 38036639
doi: 10.1038/s41598-023-48199-x
pii: 10.1038/s41598-023-48199-x
pmc: PMC10689821
doi:
Substances chimiques
Thyrotropin
9002-71-5
Thyroxine
Q51BO43MG4
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
21096Subventions
Organisme : Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea
ID : HI22C1078
Organisme : Tech Incubator Program for Startup through Korea Business Angels Association, funded by the Ministry of SMEs and Startups, Republic of Korea
ID : S3286890
Informations de copyright
© 2023. The Author(s).
Références
Circulation. 2007 Oct 9;116(15):1725-35
pubmed: 17923583
J Clin Endocrinol Metab. 2010 Jan;95(1):186-93
pubmed: 19906785
Arch Intern Med. 2012 May 28;172(10):799-809
pubmed: 22529182
Clin Endocrinol (Oxf). 2012 Dec;77(6):911-7
pubmed: 22724581
Lancet. 2001 Sep 15;358(9285):861-5
pubmed: 11567699
J Am Geriatr Soc. 2013 Jun;61(6):868-874
pubmed: 23647402
Emerg Med Clin North Am. 2014 May;32(2):277-92
pubmed: 24766932
J Community Hosp Intern Med Perspect. 2014 Nov 25;4(5):25502
pubmed: 25432651
Clin Endocrinol (Oxf). 2010 May;72(5):685-8
pubmed: 20447066
JMIR Mhealth Uhealth. 2018 Jul 13;6(7):e159
pubmed: 30006328
Cureus. 2021 Sep 7;13(9):e17786
pubmed: 34659997
Endocrinol Metab (Seoul). 2021 Oct;36(5):1121-1130
pubmed: 34674500
Clin Endocrinol (Oxf). 1991 Jan;34(1):77-83
pubmed: 2004476
J Intern Med. 1991 May;229(5):415-20
pubmed: 2040867
Thyroid. 2016 Oct;26(10):1343-1421
pubmed: 27521067
Endocr Rev. 2005 Aug;26(5):704-28
pubmed: 15632316
Clin Endocrinol (Oxf). 2012 Jul;77(1):146-51
pubmed: 22283624
Horm Metab Res. 2020 Dec;52(12):850-855
pubmed: 32886945
Int Clin Psychopharmacol. 2023 Jul 1;38(4):269-272
pubmed: 36853810
Lancet. 2012 Mar 24;379(9821):1142-54
pubmed: 22273398
J Clin Endocrinol Metab. 2012 Mar;97(3):852-61
pubmed: 22238391
J Clin Endocrinol Metab. 2014 Jul;99(7):2372-82
pubmed: 24654753
J Clin Endocrinol Metab. 2011 Jan;96(1):E1-8
pubmed: 20926532
Thyroid. 2017 Apr;27(4):491-496
pubmed: 28001121
Endocrinol Metab (Seoul). 2013 Dec;28(4):275-9
pubmed: 24396691
J Endocrinol Invest. 2008 Oct;31(10):856-60
pubmed: 19092288
Arch Intern Med. 2007 Jul 23;167(14):1533-8
pubmed: 17646608
Thyroid. 2016 Jan;26(1):1-133
pubmed: 26462967
J Clin Oncol. 2013 Nov 10;31(32):4046-53
pubmed: 24101052